Key Highlights
- Hims & Hers launches the Service Appreciation Initiative for U.S. military, veterans, teachers, nurses, and first responders.
- Compounded GLP-1 subscriptions available for as low as $99 per month.
- Supports weight loss through a comprehensive, personalized approach including GLP-1 medications, nutrition, and exercise plans.
- High safety and quality standards with medications fulfilled by state-licensed, FDA-regulated facilities.
Source: Business Wire
Notable Quotes
- “Safe and affordable healthcare solutions for every individual should be the status quo. This initiative has the potential to make a lasting impact in our communities by providing more reliable, consistent access to these life-changing medications for the millions of Americans who want a better, more affordable way to take care of their health.” — Andrew Dudum, CEO and co-founder at Hims & Hers
- “When you’re giving so much to others, it can be hard to give back to yourself. Hers Weight Loss Program customer. ” — Robin Seale, Hers Weight Loss Program customer
SoHC's Take
The Service Appreciation Initiative by Hims & Hers stands out as a thoughtful, impactful effort to provide critical weight loss solutions to frontline workers and service members. By addressing affordability and access, especially for those serving in high-stress roles, the company is taking a step toward making long-term health benefits more achievable. GLP-1 medications, which play a significant role in promoting healthy weight loss, are a cornerstone of this initiative, and the personalized care approach ensures tailored support. This initiative is not just a health offering; it’s a recognition of the value of our essential workers.
Heading
Related

Hims & Hers Adds Affordable GLP-1 Injections to Weight Loss Portfolio
Key Highlights GLP-1 injections added to Hims & Hers' weight loss options Personalized weight loss treatments with medical support Access to medications with the same active ingredients as Ozempic® and Wegovy® Partnership with leading US manufacturer for high-quality compounded injectables Holistic weight management combining medications and lifestyle changes Source: Business Wire Notable Quotes “The core…

AffyImmune Therapeutics Expands Board of Directors with Key Appointments
Key Highlights AffyImmune Therapeutics announces the appointment of Rick Rutter, Ph.D., and Jorge Nieva, M.D., to its Board of Directors. Appointments bolster AffyImmune’s AIC100 CAR T cell therapy development for advanced thyroid cancers and non-small cell lung cancer (NSCLC). Rutter and Nieva bring decades of experience in CMC regulatory strategy and clinical oncology. AffyImmune’s AIC100 is nearing completion of Phase 1 trials for thyroid cancer and…

Catherine Owen Adams Appointed CEO of Acadia Pharmaceuticals
Key Highlights Catherine Owen Adams appointed CEO, succeeding Steve Davis. Adams brings extensive global experience from Bristol Myers Squibb and Johnson & Johnson. Acadia advances treatments for Parkinson’s disease psychosis and Rett syndrome. Adams aims to accelerate growth, innovation, and new partnerships. Source: Business Wire Notable Quotes “Catherine is a proven global leader with a distinguished record of…